Mysimba - direct healthcare professional communication (DHPC)

bupropion hydrochloride / naltrexone hydrochloride
DHPCHuman

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

Over

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documenten

Direct healthcare professional communication (DHPC) : Mysimba (naltrexone/bupropion): long-term cardiovascular risk and new recommendations on annual assessment

English (EN) (138.39 kB - PDF)

Publicatiedatum:
Bekijk

Key facts

Medicine name
Mysimba
Active substance
  • bupropion hydrochloride
  • naltrexone hydrochloride
Procedure number
EMEA-H-A-20-1530
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
A08AA
Dissemination date

Share this page